ENXTPA:SANPharmaceuticals
Sanofi (ENXTPA:SAN) Valuation Check As CEO Transition Follows Pipeline And Vaccine Unit Challenges
Why the CEO change matters for Sanofi shareholders
Sanofi (ENXTPA:SAN) is in the spotlight after the board decided not to renew Paul Hudson’s director mandate, setting his final day as CEO for February 17 and naming Belén Garijo as his successor from April 29.
This leadership shift comes after reports of clinical setbacks, pressure in the US vaccine unit, limited expected pipeline catalysts for 2026, and a cautious reaction from investors, including at least one broker downgrade to...